Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Metronomic Chemotherapy Using POLF Regimen in the Treatment of Advanced Gastric Cancer

NCT02855788 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT02855788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02855788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Metronomic Chemotherapy Using POLF Regimen in the Treatment of Advanced Gastric Cancer
Lead sponsor
Huashan Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2015
Completion date
October 31, 2018
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced gastric cancer, metastatic gastric cancer